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ABSTRACT
West Nile virus (WNV) inhabits a unique position in the infectious disease landscape. It is both
the most widespread arbovirus in the world, and yet is one of the least known. WNV is spread by
mosquitoes and has high morbidity and mortality in birds, humans are dead-end hosts of the virus but can
develop a serious neuroinvasive form of the disease (WNND). The incidence of such cases is on the rise
around the world.
To explore WNV, we created a comprehensive phylogenetic analysis with all available WNV
genomes in genbank database using Nextstrain to identify use cases for increasing WNV genomic
sequencing by investigating the following phenomena: lineage specific substitution rates, mutations of
interest, and the introduction and spread of WNV into Europe.
The substitution rates were 2.89e-4 and 2.62e-4 for European lineages 1a and 2 respectively.
Implying that lineage 1a historically has had a greater effective population size than lineage 2. The fact
that lineage 1a in Europe historically had fewer confirmed cases while in circulation compared to lineage
2 indicates one of three things; cases were more likely to be missed prior to lineage 2, lineage 1a infects a
greater number of bird species, or lineage 2 is more likely to lead to human cases. An investigation of
mutation Env:159V from the strain NY99 that was introduced and subsequently spread across the
Americas was also identified in Israel 1998 and two years later in Hungary, yet this clade never
maintained transmission outside the Americas. Our findings highlight the importance of increasing whole
genome sequencing to identify mutations of interest. Lineage 1a and 2 each have one introduction
responsible for the majority of sequences and these introductions are characterized by slow spread over
the course of many years. While limited by sparse sampling, this indicates that novel introductions that
lead to sustained transmission are rare events and spread slowly, taking many years upon introduction to
lead to human cases or surveillance is failing to identify cases early. In both scenarios improving
surveillance can help public health identify and employ timely prevention measures.

2

TABLE OF CONTENTS
List of Figures………………………………………………………………………………………………3
Introduction…………………………………………………………………………………………………4
Results………………………………………………………………………………………………………8
Figure 1…………………………………………………………………………………………….9
Figure 2…………………………………………………………………………………………...11
Figure 3……………………………………………………………………………………….…..12
Figure 4…………………………………………………………………………………………...14
Figure 5……………………………………………………………………………………….…..18
Figure 6……………………………………………………………………………………….…..22
Discussion…………………………………………………………………………………………………22
Figure 7……………………………………………………………………………………….…..24
Figure 8……………………………………………………………………………………….…..26
Limitations…………………………………………………………………………………………….…..27
Figure 9……………………………………………………………………………………….…..28
Conclusion…………………………………………………………………………………………….…..29
Methods……………………………………………………………………………………………….…..29
References…………………………………………………………………………………………….…..31

3

LIST OF FIGURES
Figure 1: Global Genome Submissions Over time

Figure 2: Molecular clock of Lineages 1 and 2

Figure 3: Envelope 159 mutation in lineage 1a

Figure 4: Lineage 1a Introduction and Spread into Europe

Figure 5: Lineage 2 Introduction and spread in Europe

Figure 6: Spatio-Temporal Trends of lineage 1a, 2 and usutu

Figure 7: Exploded Tree by Continent

Figure 8: Spatio-Temporal Trends of lineage 1a, 2 and usutu by country

Figure 9: Low-Sequencing Continents

4

INTRODUCTION
Background
West Nile virus (WNV) inhabits a unique position in the infectious disease landscape. It is both
the most widespread arbovirus in the world, existing on every continent except Antarctica, and one of the
least known. (Kramer et al., 2008) The global dispersal of WNV can be attributed to its prolific tropism in
a wide variety of species. In the NCBI database used for this study, 243 different species have been
sequenced for WNV including 129 species of bird. WNV is primarily maintained in an enzootic cycle
between mosquitoes and birds with humans being dead-end hosts. Even though humans don’t develop
high enough viremia to spread the disease, we can develop a serious form of the disease known as West
Nile Virus Neuroinvasive disease (WNND) which can lead to encephalitis and death. WNV is more
severe in avian populations, developing high enough viremia to spread it to one another via mosquito
causing high mortality. Corvids are especially vulnerable, with estimates indicating population declines of
American crows as high as 45% in North America. (LaDeau et al., 2007) How WNV spreads and
maintains itself in winter colder climates, given mosquitoes are the primary vector is still a mystery.
Migratory species such as storks have been implicated spreading WNV to novel geographical locations
(Malkinson et al., 2002) and residential birds such as American Robins and house sparrows have shown
to be important drivers of enzootic maintenance, even demonstrating the possibility of horizontal
transmission in the absence of a mosquito or sustained positivity throughout winter. (Komar et al., 2003)
A study testing overwintering mosquito pools in the Czech Republic found positive detection of lineage 2
(Rudolf et al., 2017). Additional research has shown that vertical transmission from infected mosquito to
progeny is possible. (Nelms et al., 2013) yet the degree to which WNV is introduced versus locally
maintained in different regions is still unclear.
Understanding this transmission dynamic is key for public health agencies to respond to evidence
of WNV in their region. Recent novel transmissions may indicate swift action is needed to ramp up
surveillance and mosquito control to prevent the virus from becoming entrenched and leading to an
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outbreak of human cases. In contrast, locally sustained transmission may indicate the need for public
messaging of widespread human risk and prevention measures. Temporal information is also critical,
evidence of repeated introductions year-over-year could stymie elimination efforts, and repeated evidence
of sustained transmission year-over-year could indicate the need to prepare for cyclical outbreaks in the
future.
Phylogenetic analysis can help shed some light on the transmission cycle scenarios above by
helping determine whether a positive sample is genetically similar to any previously identified samples in
the region of interest or similar to samples collected in another country or continent, providing a temporal
and spatial estimate. Geographically dispersed and routine sequencing can increase the confidence in
findings as phylogenetic analyses are unique subject to sampling bias. Each genome is only defined by its
relative relationship to another. Dense geographical and temporal clustering increases the likelihood of a
region being linked as the source of an outbreak. (Hill et al., 2021)

Knowledge Gap
Unfortunately, WNV sequencing globally is considerably lacking. There are only 343 WNV
genomes outside of North America available on NCBI, the primary database for WNV genomes.
Compare this to SARS-CoV-2 which has over 10 million publicly available sequences. Given WNV
global dispersal and wide tropism, this feels akin to trying to understand the world by living in a single
room peering through a keyhole. However, this disparity isn’t entirely unjustified. Since its accidental
discovery in 1937 during a serological survey for Yellow Fever in Uganda, it has been associated with
relatively mild disease for most of the 20th century with mild outbreaks in Israel between 1950 and 1954.
(Marberg et al., 1956) Approximately 80 percent of cases are asymptomatic. Serological surveys
conducted around the world have shown that WNV is widely disseminated and is thought to have both
originated and be maintained on the African continent. Studies in Egypt and southern Sudan showed 61
and 40 percent seroprevalence without historical indications of large scale morbidity and mortality.
(Taylor et al., 1956)
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Growing Threat
Yet, the burden of WNV may be even far greater than we realize. Roughly 1 percent of human
causes can develop into a potentially fatal form of WNV known as West Nile Neuroinvasive disease
(WNND), in the USA where surveillance is well established, it is the most common cause of viral
encephalitis in the country. (Davis et al., 2006) In countries with higher burdens of infectious disease, the
problem may be masked by other diseases with similar symptoms. In Africa where malaria, dengue and
chikungunya are cocirculating it is especially challenging. A study in a South African hospital
investigating neurological diseases of unknown etiologies found that 17% of the patients had WNV
neutralizing antibodies, significantly more than in similar earlier serosurveys. (Zaayman & Venter, 2012)
WNV outbreaks are unpredictable. While serological evidence dates WNV circulation in much of
Europe to the 1960’s, (Metz et al., 2021) an 1996 outbreak of lineage 1a in Romania and 1999 outbreak in
Russia were particularly severe and had uncharacteristically high mortality with 13 and 5 percent case
fatality respectively, Only to have it subside in subsequent years. (Campbell et al., 2001; Platonov et al.,
2001; Garske et al., 2009) Lineage 1a was circulating in Italy for at least 10 years, causing primarily
equine cases until the first human WNND in 2008. (Rossini et al., 2008) Lineage 2 was thought to be
associated with mild disease until its emergence into Europe in 2004 leading to a sharp rise in human
cases. Recent studies have shown that virulence of West Nile virus is associated with site specific
mutations rather than lineage, which may explain the heterogeneity in severity and timing of outbreaks
despite continuous circulation. (Botha et al., 2008) Given humans are incidental hosts, there is no telling
what future evolutionary advantages of WNV in the enzootic cycle will mean for human WNND. This
highlights the importance of whole genome sequencing (WGS), where identifying genotypic indicators of
virulence within a population will allow public health agencies to warn the public.
The geographical spread and intensity of WNV outbreaks has only been increasing in recent
years. In 2018 the largest outbreak of WNV Europe erupted causing over 3,000 confirmed cases, three
times as many cases as any previous year and continues to expand its range. (Bakonyi & Haussig, 2020)
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In 1999, one of the most significant arbovirus events in history occurred with introduction of lineage 1a
into the United States. Within a few short years it spread across all of the Americas from Canada to
Argentina, causing over 25,000 cases of WNND and 2,456 deaths in the USA. (Final Cumulative Maps
and Data | West Nile Virus | CDC, 2022) WNND not only causes mortality but morbidity as well, a 2014
survival analysis of patients 8 years post infection found that 40 percent of patients were still experiencing
some form of symptoms. (Murray et al., 2014) Climate change is predicted to make incidence of West
Nile virus worse by expanding competent vector habitats, prolonging transmission season, increasing
transmissibility and increasing mosquito population sizes. (Paz, 2015; Samy et al., 2016; Vogels et al.,
2016) Tracking the spread and trend of WNV is key to ensuring that we are not taken by surprise.

Importance of Paper and Findings
Fortunately with the exponential growth of Next Generation Sequencing (NGS), it is more
affordable than ever to process genetic information. It has outpaced Moore's Law with the cost of
sequencing the entire human genome approaching $1,000. (Check Hayden, 2014, p. 000) Nextstrain, the
primary tool for this analysis, makes it easier than ever to analyze genomic information into usable and
shareable tools to investigate the phylodynamics of WNV. While numerous studies have conducted large
scale phylogenetic analysis of WNV in both the Americas, (Hadfield et al., 2019) in Europe (Srihi et al.,
2021) globally for lineage 1a, (May et al., 2011), or reviewed select samples of all lineages for genetic
comparisons, (Pesko & Ebel, 2012) none to our knowledge have conducted a comprehensive global
analysis of all available West Nile lineages to date. In addition, few studies have analyzed genomic
epidemiological comparisons of both lineages 1a and 2 in conjunction. This paper is timely, the utility of
comprehensive genome surveillance has proven to be critical in identifying and tracking the spread of
SARS-CoV-2 and WNV sequencing has decreased in recent years. Our hope is that this paper can help
provide the utility of converting some of the momentum from SARS-CoV-2 efforts to WNV.
By utilizing Nextstrain, we demonstrate the utility of a comprehensive phylogenetic analysis of
WNV by focusing on lineage 1a and 2 in Europe and found that lineage 1a was very undersampled and
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likely more widespread during the second half of the 19th century throughout Europe than lineage 2 is
today, yet was associated with fewer cases. Next we explore the key amino acid substitution in envelope
159V in the NY99 strain to highlight the impacts of ecology on purifying selection as well as conducting
whole genome sequencing (WGS) to identify strains greater transmissibility and epidemic potential.
Lastly, we explored WNV phylogeography and found that introductions that lead to sustained
clades transmission appear to be rare events, rarely occur in large geographical jumps and these clades
appear to emerge and be subsequently replaced. Utilizing epidemiological data of six countries, we
calculated a mean delay of five years between the inferred introduction date of lineage 2 indicating that
surveillance efforts would need to be increased for more timely detection of WNV.
The unpredictability of WNV virulence, combined with our findings that successful introductions
are rare and often die out and WNV is a slow moving disease, highlights the importance of improving
genomic surveillance to identify virulent or transmissible strains and determine patterns of transmission.
If we can better understand these transmission networks, we can better target control efforts to reduce the
likelihood of spillover into humans and prepare for increased transmission in the event of a discovery of a
more virulent or transmissible strain.

RESULTS
Sample Selection
There were 6,461 West Nile virus samples available in the NCBI database (excluding
experimental samples). After removing missing metadata and downsampling the USA, 742 genomes were
included in the analysis 343 were from outside North America. Sequencing as a whole has increased
dramatically over the last two decades, but has not kept pace with the cases reported around the world and
essentially fell off a cliff in 2019 and 2020, likely disrupted by the SARS-CoV-2 Pandemic. Because
WNV is so divergent, the lineage can be identified by only sequencing the envelope or non-structural
protein 5 (NS5). Thus many surveillance strategies only sequence specific regions of the genome.
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Unfortunately envelope genomes are not reliable enough for determining tMRCA and conducting more in
depth genomic analysis. With the dramatic decrease in sequencing costs and demonstrating the use of
whole genome sequencing in this paper we hope to encourage surveillance programs and researchers to
include critical metadata and sequence whole genomes in the future.

Figure 1: Global Genome Submissions Over time
USA not included. Grey indicates partial genome which were not included in Nextsrain build. Usutu
virus, a relative of WNV, is identified in a similar manner to WNV through the collection of dead birds and
is thus included as a metric for how much sequencing is being done.

Substitution Rate
The substitution rate is the rate at which random mutations are expected to become fixed at any
given site (base pair) along an organism's genome per year. The substitution rate is impacted by the
mutation rate, generation time, effective population and fitness of the mutation. (Scholle et al., 2013) If
we assume that mutations are occurring randomly at some relatively constant rate, and generation time is
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fixed, this provides us with the ability to speculate on the effective population. Because mutations are
random and often deleterious, a larger effective population means more opportunities for non-deleterious
mutations to survive and become fixed. Utilizing substitution rates in conjunction with seroprevalence
surveys of birds allows us to estimate the prevalence in avian and mosquito populations where we don’t
have case data. It should be noted that inferences based on substitution rates West Nile virus are
challenged by the differential evolutionary dynamics between mosquitoes and avian hosts, where
mosquitoes demonstrate higher intra-host diversity signaling weaker purifying selection when compared
to avian hosts where the virus is constrained by the need to develop high enough levels of viremia lead to
subsequent transmission. (Grubaugh & Ebel, 2016) However, we can still apply some general principles
of genomic epidemiology to gain using a General Time Reversible (GTR) substitution method for all
WNV lineages. In doing so the mean substitution rate was 2.81e-4. substitution rate for all lineages and
2.89e-4 and 2.62e-4 for European lineages 1a and 2 respectively. This average rate is much lower than
previous estimates of 3.74e-4 which didn’t include all known samples. (McMullen et al., 2013) Given that
the substitution rate is used to infer the tMRCA of samples, our findings, if valid, indicate phylogenetic
analysis using a faster clock would be systematically underestimating the tMRCA and introductions may
be occurring even earlier than previously calculated.
A faster molecular clock can be indicative of many things, one being lineage 1a historically has
had a larger effective population (infected more birds and mosquitoes) compared to lineage 2 and/or is
infecting a wider range of species and ecosystems that have led to more fixed mutations in the population
to accommodate a more diverse host range. The long branch lengths of lineage 1a in the phylogenetic tree
support the theory that 1a has been sparsely sampled relative to lineage 2 in Europe, paired with the
increased substitution rate it indicates it had a greater effective population. Given that cases in Europe
while lineage 1a was in greater circulation [Fig 5] remained low indicates that lineage 1a either didn’t
lead to as many symptomatic human cases or surveillance for identifying symptomatic cases was worse.
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Figure 2: Molecular clock of Lineages 1 and 2
Left: molecular clock of lineages 1a and 2. Right: the molecular clock zoomed in to lineage 2 of the
Central Europe Clade (CE2) in orange and South Eastern European Clade (SEE2) in blue.

Percent Identity
In order to further investigate the evolutionary dynamics of lineage 1a nad 2, an analysis of
pairwise percent identity within lineages 1 and 2 was conducted through the following subsampling
scheme: two random samples from each lineage were selected where at least one sample of the opposing
lineage was also collected in another country in the same year. This was done in order to account for
oversampling temporarily and geographically. More than one sample from the same year could be
included if it was sampled in more than one country. The sampling was restricted to lineages 1 and 2 as
there was not enough sampling coverage for other Samples were restricted to collection dates after 1990
when sampling was more likely. The untranslated regions of the samples were not used. With the
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following scheme the 52 samples from lineage 1a were selected with 96.87% identity and 45 samples of
lineage 2 were selected with 98.20% identity.
Our results of the substitution rate line up logically with the pairwise identity test. The higher
substitution rate in lineage 1a would likely lead to an increase in sample diversity compared to the slower
substitution rate of lineage 2. This increased diversity could be explained by the introduction of lineage 1a
into the America’s, making it the more ecologically dispersed of the two. Providing it with a larger
ecological niche to fill both old world and new world birds. In addition to more diverse ecological niches,
lineage 1a simply has a greater absolute number of hosts to infect given it is geographically dispersed.
However, it should be noted that there are numerous samples that are highly divergent within lineage 2
circulating in Africa that have diverged roughly at the same time that lineage 1 and 2 diverged. These
samples were not included in the above analysis as they did not meet the subsampling criteria and could
have led to a greater diversity among lineage 2.

Figure 3: Envelope 159 mutation in lineage 1a
Amino acid change ENV 159V is shown in yellow above. It had been identified in Israel and Hungary; no
evidence shows it had continued circulation outside of the Americas.

Mutations
An investigation of the envelope region of WNV highlights the diversity that can arise from
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varying ecological niches. The envelope region is responsible for entry into cells and is an important
target of neutralizing antibodies. It has been implicated in the neurovirulence of WNV (Kobayashi et al.,
2020) One specific location of interest is the Envelope region amino acid position 159 within NY99.
Experimentally NY99 which has the valine in envelope position 159 was shown to have greater host
competence in house sparrows compared to other European lineages (Komar et al., 2003). In this location
the sample Israel 1998 (NY99) (Genbank: AF481864) had amino acid Valine, it was identified in at least
one other sample at least two years later, (Genbank: HM152773) and again in Hungary in 2003
(Genbank:DQ118127) yet this clade never maintained transmission and has yet to be identified again
outside the Americas. Upon introduction into America, a subsequent mutation in the same region from
Valine to Alanine dominated and ultimately replaced the original lineage in the USA. A sequence from
2019 in Brazil (Genbank: MT905060) has shown that the original strain with the valine mutation has
migrated down to Southern America and has persisted. This evidence begs the question why did a lineage
that dominated the New World never take hold in the Old World? [Fig.2] Experimental evidence has
shown that NY99 was highly effective in culex tarsalis (Reisen et al., 2006), a species found primarily in
the Americas, indicating that NY99 found an ecological niche that was more favorable than in the Old
world where it had to also compete with co-circulating WNV lineages. A single amino acid substitution
leading to the nearly complete replacement of NY99 emphasizes the need for WGS to identify mutations
that could lead to greater transmissibility and virulence.
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Figure 4: Lineage 1a Introduction and Spread into Europe
TOP: Lineage 1a clades: NY99, WN02 and ME1) The * indicates only one sample was identified in the
introduction. In lineage 1a both portuguese sample (8*) and Russia introduction 1 appear to be part of a
widely circulating clade in the 1960’s.
BOTTOM: Phylogenetic time-resolved tree of lineage 1a clades. (ME1 is highly divergent and thus not
shown for scaling purposes.)

==
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Lineage 1a Phylogeography
Within lineage 1a, there are four distinct introductions within Europe that led to known sustained
transmission within Europe. [Fig.4] In the literature the names for the clades differ and are often labeled
undescriptive names such as A and B, for this paper we choose to define the clades as follows: The
primary clade in South Western Europe (SWE1 shown in red), a second Eastern European (EE1 shown in
teal) Clade constituting Russia and Romania, third Eastern European Asian clade (EEA1 shown in green)
and a fourth Middle Easter Clade (ME1) in yellow. The primary South Western Europe (SWE1) is defined
by long branches in the tree, indicating numerous cocirculating spread with sparse sampling. The clade
the tMRCA for these branches are estimated to be in the 1970’s. The first reported genetic evidence of
West Nile Virus was identified in a horse in 1963 in France lines up well with the tMRCA. (Joubert et al.,
1970) Indicating that the first detection of the virus surprisingly was not far off to its estimated
introduction. This corresponds to a meta analysis done including seroprevalence and PCR data of
European countries showing that WNV was present starting around the same time period. (Metz et al.,
2021; Nikolay, 2015) Two Moroccan samples are found within the SWE1 clade (AY701413 and
AY701412) from 2003 and 1996, indicating that introduction to and from Africa and Europe during this
time period occurred. This finding is important in that a body of water separates the introduction requiring
some form of migration and falls in line with the east Atlantic flyway. [flyways] The tMRCA for these
samples average 33.5 years and are more genetically similar to the European samples than to one another.
Indicating one of two things, WNV was introduced on two separate occasions and are distinct clades or
the virus is freely circulating between the two continents and is going undetected due to undersampling.
Additional evidence of introduction into Europe was the 2016 Spanish sample (MW915462). It is highly
divergent from the primary clade with the tMRCA nearly a 100 years apart but no evidence exists that this
introduction took hold. Given sampling is sparse in Spain, this may be due to under sampling. This
provides evidence that while numerous introductions have occurred only the SWE1 showed clear
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evidence of sustained transmission indicating the challenges of WNV introduction to take hold in a
region.
The last known sample from this clade was sequenced in 2015 from France. A dramatic increase
in sequencing as a result of the 2018 epidemic (Fig.1, Fig. 4) found no evidence of its continued
circulation. However, a recent sample from a sick goshawk in 2020 in Italy provides evidence that lineage
1a is still present in Europe. (Genbank: MW627239) The sample falls within the primary South West
European clade and is most closely related with other Italian samples. This finding is important as Italy
has sequenced the most samples of any country during this time period, despite this surveillance efforts
there is evidence maintained silent transmission cycles of WNV year-to-year. Indicating that more may
need to be done to track this virus.
This SWE1 Clade was not associated with serious human disease with outbreaks identified in
horses as was generally considered not a public concern for much of the 19th century due to the absence
of WNND. (Chancey et al., 2015). However, the genetically similar EE1 clade emerged in 1996 and 1999
Romania and Russia suffered serious outbreaks with unusually high mortality rates (Fig. 6) collected
within the countries during this time show them genetically related and share three nonsynonymous
mutations (NS1 L206F, NS2B A103V, and NS5 T898I) that are unique within the larger clade and could
warrant further research and highlights the importance of routine sequencing to both to identify and
monitor genetic determinants of virulence to inform public health response.
The last clade ME1 (Fig.4 yellow) is highly divergent from the rest of lineage 1a and has tMRCA
in the 1900’s that consisted of Azerbaijan, Russia, Israel, Portugal and India.The majority of the samples
are from the 1960’s. The inclusion of Portugal within this clade indicates this clade was geographically
widespread and had made its way into Europe. However, it hasn’t been identified in Europe since 1970 in
Azerbaijan. It has recently reemerged in India in 2015 indicating it has either migrated to Asia or
continues to silently spread around the continent for over a hundred years. The slower substitution rate of
this sample (2.78e-4) may indicate that its effective population is smaller and has been circulating at low
rates. This previous circulation followed by the subsequent reemergence of SWE1 begs the question of
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whether ecological changes, depletion of susceptible hosts, or competition with SWE1 led to the
disappearance of ME1 in Europe. With such sparse sequencing and epidemiological information this
question remains a mystery.
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Figure 5: Lineage 2 Introduction and spread in Europe
TOP: Phylogeography of Lineage 2 clades. * indicates only one sample was identified in the introduction.
For lineage 2, introduction 2 is the root of both clades CE2 and SEE2.
BOTTOM: Phylogenetic Tree of clades

19
Lineage 2 Phylogeography
Within lineage 2, only two known introductions have led to sustained transmission. [Fig.6] The
first introduction based on the tMRCA is the Eastern European (EEA2) Clade introduced in 1997 to
Russia. Based on the phylogeny, it is most genetically similar with samples collected in Iran and
subsequently Africa, however the confidence in this relationship is low with the tMRCA dating back to
1918. It then progressed from Russia to Romania and Italy sometime in 2004 and appeared to be
sustaining transmission in Russia and Iran until at least 2018. This clade provides a relatively clear
spatio-temporal spread from Africa through western Asia into Europe, although the sparse sampling in
this region reduces confidence that this is the exact path, as there are numerous pathways the virus could
have taken. This clade does highlight the importance of Russia, specifically the Volgograd region as a
place for surveillance, with Russia being implicated in three introductions for lineage 1a and one for
lineage 2 and was the location for the discovery of the novel lineage 4. This conclusion is supported by
both epidemiologic data reporting continuous outbreaks of WNND in Russia and ecological importance
for migratory birds. (Shartova et al., 2022) There was a third introduction into Ukraine with a tMRCA of
1978 (Genbank JX041631) and is most closely related to a Senegalese sample and the first sample ever
sequenced from Uganda in 1937 (Genbank AY532665). While no additional sequences were submitted,
surveillance efforts have shown that some continued transmission occurred. Given its proximity to Russia
and Romania, known hotspots for WNV, it provides additional evidence that increased surveillance in this
region would be warranted.
The second introduction formed the predominant clade. This introduction was first identified in
2004 in Hungary from a sick Goshawk (Genbank: DQ116961). (Fig.4) The tMRCA indicates that lineage
2 had likely been circulating for approximately five years prior in 1999 and two years after EEA2 inferred
introduction. This falls in line with previous estimates (Srihi et al., 2021) This introduction quickly
bifurcates into two clades in 2002. For the purposes of this paper the clade primarily consisting of
Germany, Austria etc. will be referred to as Central Europe Clade (CE2) and the other consisting
primarily of Greece and Serbia as the South Eastern Europe Clade (SEE2). Phylogenetic analysis of SEE2
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suggests that Greece has been sustaining the transmission year to year and continues to spill over into
neighboring countries. This may be due to the region's temperate climate that allows for more sustained
transmission. A sequence from Belgium was linked to this clade, however subsequent epidemiological
investigation determined that the case was imported from Hungary emphasizing the importance of
epidemiological investigation paired with genomic surveillance. (Wollants et al., 2018)
Looking first at our continent wide case counts and sequencing data starting from 1990 [Fig.6] we
can see that lineage 1a was circulating with few human cases. Then, as lineage 2 emerges with clade CE2
and SEE2, so do the cases. With mosquitoes being the primary host sequenced we can’t say for certain
that lineage 2 was responsible for all the human cases, the circumstantial evidence would suggest so.
Either the strain of lineage 2 is potentially more virulent than previously thought causing more
symptomatic cases, or the number of all cases identified has risen through improved surveillance and
awareness. This strain has six nonsynonymous amino acid mutations that are unique to clades CE2 and
SEE2 and could be the subject for future investigation. (NS1 K44R, NS2B M88I, NS3 K11R, NS4B
A23T/S31N, NS5 K190R)
Analyzing clade CE2 within lineage 2 provides interesting insights into potential silent spread of
West Nile. Both Germany and Austria have been conducting some form of West Nile surveillance soon
after the introduction in 2004 into Hungary. The first cases of West Nile were reported in 2018 in
Germany and Austria in 2014. Evidence of WNV in Austria was first identified in 2008 in a goshawk and
the first case was identified in 2009. Active surveillance of birds within Germany, a paper published in
2011, (Ziegler et al., 2012) found no evidence of WNV, yet the German sample (Genbank: LR743454)
indicates there may have been an introduction as early as 2005, although with no subsequent samples of
this clade it may have not led to sustained transmission. Within the CE2 clade Germany appeared to have
either four separate introductions, or silent spread for nearly a decade. Shared borders with Austria and as
well as intermixing of both countries within the clades point to the latter possibility. We looked at six
countries in clades SEE2 and CE2 (Germany, Austria, Slovakia, Greece, Serbia, Netherlands) with at least
two samples of lineage 2 and found a five year delay between the inferred date of introduction (tMRCA)
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into the country and the identification of the first case and 3.2 years between the first sequenced genome
and the inferred date of introduction (tMRCA). [Fig.8] These findings imply one of three things, either
cases were going undiagnosed for many years before they were identified and registered in the
surveillance system or WNV took many years to build up a critical number of infected birds to spill over
into humans, or our estimates are off due to undersampling. If it truly takes an average of five years
before a case, this gives public health agencies ample time to implement mosquito control measures to
prevent spillover if WNV is identified. All scenarios point to the need to increase genomic and case
surveillance efforts if we want to understand the dynamics of this disease.
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Figure 6: Spatio-Temporal Trends of lineage 1a, 2 and usutu
Provides an overlap with sequencing efforts and lineage circulation with human cases. Note that cases
within the gray box are prior to publicly available European CDC reports and are inferred from case
reports. Partial genomes are included in the graphs. Cases include Israel.

DISCUSSION
Introductions
Looking at lineage 1a and 2 introductions by continent side by side in figure 7, we see evidence
of multiple introductions into Europe (orange) yet few appear to lead to sustained transmissions as
indicated by multiple nodes with only one descendant. This is indicative of two things; either
introductions occur with some frequency but given the bottlenecks that WNV has to undergo to maintain
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transmission they rarely lead to sustained transmission, or surveillance is missing the sustained spread of
these introductions. The relative increase in sampling in recent years after the introduction of lineage 2
without an increase in introductions would suggest the former, yet the fact that many of the isolated
introductions occurred in countries with little overall sequences (Ukraine: 1, Cyprus: 2, Spain: 5) would
suggest the latter. Only increasing surveillance globally could help answer this question. If introductions
leading to sustained transmission are common, suppression rather than elimination efforts of WNV could
be more cost-effective and tracking new genotypes for virulence would be crucial.
Looking at the length of branches of those introductions we see that most branches span decades
indicating the spread of WNV is slow moving, likely disseminated by overlapping habitats of residential
or partially migratory birds. We rarely see geographical leapfrog type movement that would indicate
sudden transition events from long range bird migration season-to-season. This could be due to
undersampling in Africa where many birds migrate from Europe in the winter. Given that we do see some
introductions between Morocco and Southwestern Europe in the SWE1 clade, migratory birds may help
push the virus across geographical barriers. If we want to understand the importance of migratory birds,
sequencing efforts should be focused on flyways such as Morocco and Spain as well as Italy and Tunisia.
The introduction from Israel in 1998 to New York in approximately the same year was the biggest
anomaly in the data with the largest geographical jump. Such a large jump indicates introduction caused
by some human activity as no common bird migration occurs from Israel to New York. Upon introduction
into New York the virus spread out in a bush like topography (Hadfield et al., 2019) in nearly every
direction, indicating that migratory birds that primarily travel north south were likely not the only source.
Studies have indicated that residential species such as the house sparrows and jays are likely important
maintainers of the virus once introduced. (Muzaffar et al., 2012)

24

Figure 7: Exploded Tree by Continent
Long branches indicate extended time to the tMRCA in a different continent and a single point with no
subsequent descendants indicate a single transmission event with no known sustained transmission.

Phylogeographic Trends
While little is known about WNV during the early 19th century, our phylogeographic analysis
found that the ME1 clade of lineage 1a was widely circulating around the Mediterranean only to
disappear following the emergence of the SWE1 clade in the 1960’s. Which based on serologic evidence
had been circulating with some regularity in South Western Europe to some degree roughly from the
1960’s to the 2000’s (Metz et al., 2021). SWE1 largely disappears with the emergence of usutu and
lineage 2. (Note: Usutu, is a flavivirus that is closely related to WNV. It primarily infects birds and is
identified through surveillance measures in a similar manner to WNV. Usutu rarely leads to human cases.
Usutu was included in the study as analog for how much genomic surveillance a country is conducting, as
well as inform the discussion of transmission dynamics.) In Eastern Europe we observe a similar pattern,
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with EE1 and EEA1 circulating from 1990 to 2006 only to fade away and be replaced by EEA2 in 2001
and 2018.
This pattern indicates one or more of the following scenarios, the widely circulating WNV clade
effective reproductive number drops below one through a depletion of susceptible hosts or vectors either
through increased mortality or immunity. The effective population isn’t enough to sustain it through
colder months when the effective reproductive number plummets below one (Kushmaro et al., 2015) with
lower transmission and the virus fades away, potentially remaining at low levels in hospital environments.
If true, we could expect clades to return in subsequent years as immunity fades and the number of
susceptible birds reaches the minimum size to become detectable by surveillance again as we saw with
clade SWE1 in Italy in 2020 or ME1 in India in 2015. If cross-immunity with other lineages doesn’t play
a significant factor, we could see oscillations between different lineages with a future rise of lineage 1a
and a subsequent decline of lineage 2.
Scenario two, ecological shifts and warming temperatures favor a new lineage that may be more
adept at replication at higher temperatures or in mosquitoes that are more prolific in warmer temperatures.
(Kushmaro et al., 2015; Reisen et al., 2006; Vogels et al., 2016) Changing ecologies may be leading to
die-offs of bird species that were favored by the predominant clade and lead to the subsequent rise of
species that are more adept in the remaining bird and mosquito populations. If true, we would expect for
clades to die out completely, or shift to regions that are more ecologically suitable. Perhaps lineage 1a has
continued spreading silently and will continue to remain prevalent in South West Europe and Lineage 2
will remain in Central and Eastern Europe.
Scenario three, a new clade or lineage of WNV simply outcompetes the old lineage and the
lineage is outcompeted and goes extinct or again shifts to areas where it may have some niche competitive
advantage. This scenario has played out in the US lineage NY99 was outcompeted by WN02 and been all
but eliminated from the country, but subsequent sequencing in Brazil and Argentina has indicated it found
a niche in South America. In reality, it is likely that there is a combination of the three scenarios occurring
to some degree and ultimately happens in the real world, only time will tell.

Understanding this
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dynamic could provide insights into the timing and duration of potential outbreaks to improve timing of
interventions as well as the transmission networks between regions. Targeting these networks at specific
times could improve the efficacy of intervention efforts.

Figure 8: Spatio-Temporal Trends of lineage 1a, 2 and usutu by country
Provides an overlap with sequencing efforts and lineage circulation with human cases broken down by
country. Note that cases within the gray box are prior to publicly available European CDC reports and
are inferred from case reports. Partial genomes are included in the graphs.

LIMITATIONS
Geographical Scope
WNV is highly specific regionally within a country. The geographic resolution of this analysis was at
the country level. This was done for two primary purposes, the region-specific data within a dataset is
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often left blank and the analysis of that data becomes far more complex. Future synthesis of state level
information and improved submission requirements could make region level analysis possible.

Sample Bias
Currently one of the challenges of WNV phylogenetics is the sparse sampling globally. [Fig. 9] In
Africa it is especially a challenge where the majority of lineages have been thought to originate. This
limits our ability to infer introductions and chains of transmission. This made determining what could be
considered an introduction for lineage 1a more difficult as the confidence in the data and the tMRCA
between samples often spanned decades. In comparing lineage 2 verse 1a, the challenge arises that the
growth in sequencing globally has corresponded with the introduction of lineage 2. This would likely bias
the results to indicate there was a greater number of introductions because of enhanced surveillance
efforts identifying more clusters. However, interestingly this is not the case. We see a far greater number
of introductions in lineage 1a.
Within our data, the United States is drastically over-represented, constituting 70% of the samples
in Genbank. Oversampling is an issue as it can over-represent said areas in the internal nodes. (Hill et al.,
2021) However, because humans are dead end hosts, it does allow us to make more inferences about the
flow of the disease through ecological means. An additional and easily fixable issue with our data is the
impact of missing metadata. Within NCBI, 396 sequences couldn’t be used because of missing metadata.
Preferential partial genome sequencing by specific countries also introduces an additional bias as samples
are unable to be reliably used within a phylogenetic analysis.
An additional challenge with sampling is the methods for determining what positive WNV
sample to sequence is not systematic and consistent between European countries and increased
sequencing is skewed toward the higher resource countries. Romania has had 2,211 cases and has four
WGS (0.002%) compared to Germany which has had 42 cases but sequenced 53 WGS (131%), this
makes Germany more likely to be considered a central node in the tree, despite the fact that Romania may
very well be the source of many outbreaks and we simply don’t have the data.
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Figure 9: Low-Sequencing Continents
Gray bars are partial sequences. The majority of Asia samples are concentrated it Israel.

CONCLUSION
This paper holds no illusions that WNV is the most pressing public health threat facing society.
Which, in part, is one of the motivating factors for this research. Synthesizing global information provides
a tool for public health agencies around the globe to coordinate and effectively target their efforts. The
changing climate may exacerbate this growing threat in unpredictable ways and understanding this
dynamic can help us be better prepared for the future. While regional sequencing is key for understanding
local dynamics, countries will not be able to understand the larger transmission dynamic without more
sequencing around the world. While our analysis found that introductions were rare and WNV often
spread slowly over many years, more sequencing in countries like Morocco, Russia, Greece, Italy, and
Israel would improve our understanding frequencing introductions across and around geographic barriers
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and inform mosquito control efforts and act as sentinel sites for migrating virulent genotypes. While our
analysis found that circulating clades in Europe seem to circulate for ten plus years only to be replaced,
provides insights into potential causes. Increasing sequencing can improve our understanding of this
phenomenon and help determine whether lineage specific cycles will emerge to improve preparation and
exploit potential weaknesses in the transmission network. Calculating substitution rates can provide us
with a since of the effective population of WNV, inform our tMRCA’s and effective population size within
the avian and mosquito populations. Investigating mutations can help us identify key amino acid
substitutions such as env 159V in America that led to the rise in WN02. Combining genomic data with
epidemiologic data can provide us with insights into the effective of current surveillance efforts, in our
analysis we found that there was a mean delay of five years between the inferred introduction date of
lineage 2 and the first case and 3.2 years between inferred introduction date and first sample sequenced.
Indicating that current efforts could be improved to catch WNV early before it becomes widespread.

METHODS
Genome Selection
Step

N

NCBI Database

6461

Complete Metadata

4404

Complete Metadata (supplemented)

5595

Complete Genome

3091

USA Downsampled

743

Usutu Samples

446

All genomes identified from NCBI database (https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/ ) using the
search for “WNV” and “Usutu” as search terms. Mouse (Mus musculus) hosts were removed due to them
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likely being from experimental studies. Samples without available year or location were removed. There
were 6,461 West Nile virus samples available in the NCBI database (excluding experimental samples)
with 4,401 having complete metadata. That is only 68 percent of genomes in the database that are usable
for phylogenetic analysis. Efforts to supplement missing metadata led to an additional 1,196 samples
(5,597 total). Of the 5,597 with complete metadata, 3,091 (55.2%) were complete genomes (Table 1). Of
those complete genomes 2,260 (73%) were from the United States. USA sequences were downsampled
Supplemental data from previously published studies that provided additional metadata was used to
complete some metadata for some samples. The list of those papers can be seen in the supplemental
information. If only year was available the month and date “06-01” was used for approximate day as an
approximation as transmission season is generally in the summer. The USA was downsampled 80% for
each sublineage NY99, WN02, and SW03.
Data Cleaning
The data was cleaned using R version 4.1.2 with the tidyverse package 1.3.1. Lineages were
assigned using Genome detective wnv version 1.1. The pairwise identity was calculated using Geneious
2022.0.2. Code for preparing the data for the analysis, as well as the data sets can be found on github
https://github.com/rtobiaskoch/WNV-nextstrain.

Case Data
Cases were obtained from ECDC website from 2010 to 2020.
https://www.ecdc.europa.eu/en/west-nile-fever/surveillance-and-disease-data/historical USA cases were
pulled from CDC www.cdc.gov/westnile. Cases that weren’t the previous sources were identified from
outbreak reports and can be seen in the supplemental information.

Genomic Analysis
Lineages were assembled using MAFFT to reference genome NC_009942.1. Tree was rooted using
Nextstrains best root algorithm to provide a hypothetical root. This was done due to the issue of
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divergence between the lineages. No easily identifiable root was found. Iqtree version 2 was used for
building the tree using method GTR. Samples with more than 10 IQD’s from clock expectation were
filtered. Calculation for tMRCA was used using the inferred date from the Nextstrain build. Our
Nextstrain analysis can be found online https://nextstrain.org/community/rtobiaskoch/WNV-nextstrain/
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